/organisation/clinical-genomics-group-enterix-inc-2006-north-ryde-2001-38614.html
 
 
 
 
 
 

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Organisation › Details

Clinical Genomics (Group)

Clinical Genomics is a privately held biotechnology company developing innovative products for colorectal cancer diagnosis. With a broad intellectual property portfolio consisting of more than 20 issued and pending patents, Clinical Genomics has developed a sensitive and specific blood test for colorectal cancer based on methylated DNA from two genes, BCAT1 and IKZF1, and plans to offer this 2-gene test for CRC recurrence monitoring in the U.S. beginning later in 2016. Clinical Genomics, via its wholly-owned subsidiary Enterix Inc., currently offers the user-friendly, patient-preferred colorectal cancer screening InSure® FIT™ assay, a fecal immunochemical test that detects blood in the stool. InSure is also marketed in Australia and other countries (as ColoVantage Home). Clinical Genomics has offices and laboratories in Bridgewater and Edison, New Jersey and Sydney, Australia, and operates as an FDA-registered and TGA-licensed manufacturer and a NATA-accredited laboratory. *

 

Period Start 2006-01-01 established
Products Industry clinical genomic test (nucleic acid diagnostics)
  Industry 2 colorectal cancer test
Person Person LaPointe, Lawrence (Clinical Genomics 201708 CEO)
     
  Street 2 Eden Park Drive
  City 2113 North Ryde NSW
  Tel +61-2-9887-5300
    Address record changed: 2017-08-29
     
Basic data Employees n. a.
     
    * Document for �About Section�: Clinical Genomics Technologies Pty Ltd.. (3/23/16). "Press Release: Clinical Genomics Announces Closing of $15 Million Series A Financing Round". Edison, NJ.
     
   
Record changed: 2017-08-29

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

More documents for Clinical Genomics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px




» top